Organovo Holdings, Inc. (ONVO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Previous Close | 2.01 |
| Open | 2.16 |
| Day High | 2.16 |
| Day Low | 1.94 |
| 52-Week High | 21.96 |
| 52-Week Low | 1.56 |
| Volume | 243,634 |
| Average Volume | 843,782 |
| Market Cap | 3.67M |
| PE | -0.2 |
| EPS | -10.08 |
| Moving Average 50 Days | 3.82 |
| Moving Average 200 Days | 5.02 |
| Change | 0.03 |
Data not available
VivoSim to Carry Forward Organovo 3D Bioprinting
GlobeNewswire Inc.
Apr 23, 2025 12:05 PM GMT
SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (the “Company”) announced that it will carry forward its 3D bioprinting and legacy technology as VivoSim Labs, Inc. A name change of the Company to VivoSim Labs, I
Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements
GlobeNewswire Inc.
Apr 02, 2025 12:05 PM GMT
SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD), today r
Organovo Provides Business Update
GlobeNewswire Inc.
Mar 27, 2025 12:05 PM GMT
SAN DIEGO, March 27, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD) today pro